Correction: del Río Pascual et al. Therapeutic Adherence and Glycemic Control in the Population with Diabetes in Ceuta (Spain), a Multicultural City: A Cross-Sectional Study. Diabetology 2025, 6, 100

Text Correction

There was an error in the original publication [1]: a typographical error in the MMAS-8 Scale Cutoff Levels.

A correction has been made to Section 2.2. Variables and Data Collection, Paragraph 2, Sentence 3:

For the variable ‘treatment adherence,’ the MMSA-8 questionnaire was used, which was adapted for diabetes patients and validated in Spanish by Martínez Pérez [15]. This is a self-administered survey with eight questions. We used the Spanish version of the MMSA-8 scale to measure treatment adherence. Response categories are yes/no for each item with a dichotomous response and a 5-point likert response for the last item. The three-level categorical scale is broken down into low adherence (score of <6), medium adherence (score of 6 to <8) and high adherence (score of 8). This scale has been used in interventions and programs designed to improve treatment adherence in patients with diabetes. It is used as an initial assessment tool to plan specific interventions [16]. MMSA-8 is practical, reliable and validated, and is used in various clinical and research settings for different diseases and in several countries. In addition, it is mentioned that its results coincide with those of other measurement methods, which confirms its reliability [17].

Missing Acknowledgements

In the original publication [1], permissions information regarding MMSA copyright was not included in the Backmatter Section:

Acknowledgements: Use of the MMSA is protected by US copyright laws. Permission for use is required. A license to use the Morisky scales can be obtained through MMAR, LLC, dba adherence Donald.morisky@moriskyscale.com.

The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.